tradingkey.logo
tradingkey.logo
Search

Greenwich Lifesciences Inc

GLSI
Add to Watchlist
13.500USD
-0.520-3.71%
Close 07-31 16:00ETQuotes delayed by 15 min
198.16MMarket Cap
LossP/E TTM

GLSI Financials

See Greenwich Lifesciences Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Greenwich Lifesciences Inc Earnings Date

Latest Release
Jun 4, 2026
EPS / Forecast
-0.39/-0.33
Revenue / Forecast
0.00/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-1.43
-17.89%
Analyst Rating
BUY
2026/08/01
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-57.01%-0.39
7.13%-0.57
-49.89%-0.30
-49.06%-0.30
-28.63%-0.25
-186.05%-0.61
-9.08%-0.20
-59.35%-0.20
-16.28%-0.19
4.60%-0.21
---0.19
---0.13
---0.17
---0.22
----
----
----
----
----
----
Revenue
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Net Profit
-73.62%-5.66M
1.46%-7.92M
-55.57%-4.15M
-54.42%-4.03M
-31.75%-3.26M
-192.72%-8.04M
-11.58%-2.67M
-60.08%-2.61M
-16.39%-2.47M
1.57%-2.75M
-3.14%-2.39M
-118.26%-1.63M
-7.88%-2.12M
-18.21%-2.79M
-168.68%-2.32M
0.49%-746.07K
-229.92%-1.97M
-105.10%-2.36M
-236.02%-863.12K
-256.29%-749.75K
Revenue
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Operating profit
-74.44%-5.73M
1.72%-7.94M
-52.97%-4.17M
-52.02%-4.05M
-29.37%-3.28M
-185.05%-8.08M
-9.03%-2.73M
-52.27%-2.66M
-13.21%-2.54M
2.03%-2.84M
-5.03%-2.50M
-126.02%-1.75M
-12.66%-2.24M
-21.77%-2.89M
-174.96%-2.38M
-2.64%-773.31K
-231.20%-1.99M
-106.38%-2.38M
-237.41%-866.69K
-258.05%-753.45K
Net Profit
-73.62%-5.66M
1.46%-7.92M
-55.57%-4.15M
-54.42%-4.03M
-31.75%-3.26M
-192.72%-8.04M
-11.58%-2.67M
-60.08%-2.61M
-16.39%-2.47M
1.57%-2.75M
-3.14%-2.39M
-118.26%-1.63M
-7.88%-2.12M
-18.21%-2.79M
-168.68%-2.32M
0.49%-746.07K
-229.92%-1.97M
-105.10%-2.36M
-236.02%-863.12K
-256.29%-749.75K
Current assets
282.02%10.51M
50.98%6.18M
-34.61%3.81M
-56.75%3.13M
-50.06%2.75M
-41.45%4.09M
-36.32%5.82M
-33.98%7.22M
-53.77%5.51M
-48.10%6.99M
-41.53%9.14M
-36.33%10.94M
-39.67%11.91M
-50.49%13.47M
-45.90%15.64M
-42.32%17.19M
-35.07%19.74M
-5.08%27.20M
361.98%28.91M
11246.27%29.80M
Total current liabilities
263.93%5.24M
273.45%5.82M
92.55%1.62M
24.58%1.69M
269.22%1.44M
429.79%1.56M
183.36%842.38K
348.70%1.35M
65.39%389.61K
11.98%294.41K
24.97%297.29K
31.60%301.55K
-2.32%235.57K
-31.74%262.90K
-47.73%237.88K
-64.89%229.13K
-64.17%241.17K
-63.16%385.17K
-71.84%455.12K
-62.46%652.59K
Total assets
281.90%10.51M
50.91%6.18M
-34.64%3.81M
-56.77%3.13M
-50.08%2.75M
-41.47%4.09M
-36.34%5.83M
-34.00%7.23M
-53.77%5.51M
-48.10%6.99M
-41.53%9.15M
-36.32%10.95M
-39.66%11.92M
-50.48%13.48M
-45.89%15.65M
-42.32%17.20M
-35.06%19.75M
-5.09%27.22M
360.94%28.92M
10522.44%29.82M
Total liabilities
263.93%5.24M
273.45%5.82M
92.55%1.62M
24.58%1.69M
269.22%1.44M
429.79%1.56M
183.36%842.38K
348.70%1.35M
65.39%389.61K
11.98%294.41K
24.97%297.29K
31.60%301.55K
-2.32%235.57K
-31.74%262.90K
-47.73%237.88K
-64.89%229.13K
-64.17%241.17K
-63.16%385.17K
-71.84%455.12K
-62.46%652.59K
Total equity
301.60%5.27M
-86.06%353.22K
-56.15%2.18M
-75.50%1.44M
-74.37%1.31M
-62.18%2.53M
-43.72%4.98M
-44.83%5.88M
-56.17%5.12M
-49.29%6.70M
-42.55%8.85M
-37.24%10.65M
-40.13%11.68M
-50.75%13.21M
-45.86%15.41M
-41.81%16.97M
-34.40%19.51M
-2.89%26.83M
511.07%28.46M
2100.71%29.16M
Net operating income
-156.34%-4.70M
-71.40%-3.17M
-3.38%-2.67M
-113.11%-2.23M
-2.91%-1.83M
14.02%-1.85M
-43.50%-2.58M
-8.36%-1.05M
-14.50%-1.78M
0.73%-2.15M
-16.18%-1.80M
-81.52%-966.98K
20.06%-1.56M
4.16%-2.17M
-73.23%-1.55M
11.85%-532.70K
-268.65%-1.95M
-96.39%-2.26M
---894.64K
---604.32K
Net financing
1733.77%9.03M
4452.04%5.55M
183.82%3.35M
-5.73%2.61M
64.63%492.42K
--121.83K
--1.18M
--2.77M
--299.12K
--0.00
--0.00
100.00%0.00
100.00%0.00
-100.00%0.00
--0.00
---2.02M
-342.59%-5.51M
-97.62%562.60K
-100.00%0.00
--0.00

FAQs

What are the current assets of Greenwich Lifesciences Inc?

According to Greenwich Lifesciences Inc's FY2025 earnings report, its current assets were 6.18M, with a year-on-year change of 50.98.

What are the total assets of Greenwich Lifesciences Inc?

According to Greenwich Lifesciences Inc's FY2025 earnings report, its total assets of Greenwich Lifesciences Inc were 6.18M, with a year-on-year change of 50.91.

What are the total liabilities of Greenwich Lifesciences Inc?

According to Greenwich Lifesciences Inc's FY2025 earnings report, its total liabilities of Greenwich Lifesciences Inc were 5.82M, with a year-on-year change of 273.45.

What is the total equity of Greenwich Lifesciences Inc?

According to Greenwich Lifesciences Inc's FY2025 earnings report, its total equity of Greenwich Lifesciences Inc was 353.22K, with a year-on-year change of -86.06.

What is the net operating income of Greenwich Lifesciences Inc?

According to Greenwich Lifesciences Inc's FY2025 earnings report, its net operating income of Greenwich Lifesciences Inc was -19.45M, with a year-on-year change of -21.46.

What is the net financing of Greenwich Lifesciences Inc?

According to Greenwich Lifesciences Inc's FY2025 earnings report, its net financing of Greenwich Lifesciences Inc was 12.00M, with a year-on-year change of 174.64.

What is the Earnings Per Share (EPS) of Greenwich Lifesciences Inc?

According to Greenwich Lifesciences Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.43, with a year-on-year change of -17.89.

What is the net income of Greenwich Lifesciences Inc?

According to Greenwich Lifesciences Inc's FY2025 earnings report, its net income was -19.36M, with a year-on-year change of -22.61.

What is the Return on Equity (ROE) of Greenwich Lifesciences Inc?

According to Greenwich Lifesciences Inc's FY2025 earnings report, its Return on Equity (ROE) was -3068.25, with a year-on-year change of -797.27.

What is the Return on Assets (ROA) of Greenwich Lifesciences Inc?

According to Greenwich Lifesciences Inc's FY2025 earnings report, its Return on Assets (ROA) was -376.92, with a year-on-year change of -32.36.

What is the operating profit of Greenwich Lifesciences Inc?

According to Greenwich Lifesciences Inc's FY2025 earnings report, its operating profit was -19.45M, with a year-on-year change of -21.46.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.